Pharmaceuticals Archives - The Westside Story

Digital monitoring of drug adherence raises serious ethical questions

Mar 16, 2019

Recent years have seen many different efforts to leverage digital technology to address the widespread issue of non-adherence to medication prescriptions. But critics, including many experts, argue they’re neit...

Clinical trials offer new hope for cystic fibrosis patients

West Side Story

Oct 20, 2018

Health, Innovation, Science

Two new studies on a pair of triple-drug treatments may represent the first effective treatment for most patients with cystic fibrosis, a chronic, incurable condition that is frequently fatal. Researchers have ...

New analysis documents ‘severe’ withdrawal from antidepressants

West Side Story

Oct 3, 2018

Health, Science

A new UK report indicates that most patients taking antidepressants will experience substantial withdrawal symptoms when they discontinue use, according to The Guardian. For many, these withdrawal symptoms coul...

The 23andMe deal with GlaxoSmithKline raises privacy and ethics questions

West Side Story

Aug 5, 2018

Innovation, Opinion, Science

The pharmaceutical giant GlaxoSmithKline announced a move late last month to invest $300 million in the genetic testing company 23andMe, in addition to a deal giving exclusive access to its collection of geneti...

Trump signs bill allowing terminal patients to bypass FDA to try new drugs

West Side Story

May 31, 2018

Health, Policy, Science

President Trump signed the controversial “right to try” bill on Wednesday, which will allow terminally ill patients to access experimental treatments without going through the Food and Drug Administration, acco...

FDA approves first drug designed to treat migraines

West Side Story

May 18, 2018

Health, Innovation, Science

The Food and Drug Administration approved the first medication designed specifically to treat migraine headaches on Thursday, according to the New York Times. The approval represents a landmark development for ...

Purdue’s move to stop marketing OxyContin to doctors is too little too late

West Side Story

Feb 12, 2018

Health, Opinion, Science

Purdue Pharmaceuticals announced Saturday that it would stop marketing its painkiller OxyContin directly to doctors, according to NBC News, following lawsuits over its role in the wave of opiate drug addiction ...

Stronger action is needed to combat drug resistant microbes

West Side Story

May 21, 2017

Health, Opinion, Policy, Science

Already, a shocking 23,000 people die in the US each year from bacteria that have evolved a resistance to existing antibiotics. These drug-resistant infections kill an estimated 700,000 people each year globall...

Early trials for Zika vaccine show promise, safely trigger robust immune response

West Side Story

Dec 24, 2016

Business, Health, Innovation, Science

Early trials of an experimental Zika vaccine showed promise, safely triggering an immune response geared towards the Zika virus. The trial, by Inovio Pharmaceuticals, induced the response in human volunteers wh...

Study shows cancer drug prices highest in US

West Side Story

Aug 10, 2016

Business, Health

New research has examined the disproportionate nature of the prices of cancer drugs in the US. The study, made public at the American Society of Clinical Oncology’s meeting in Chicago on June 6th, examined the ...

Tagged Pharmaceuticals